Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?
- 1 September 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 37 (9) , 1539
- https://doi.org/10.1212/wnl.37.9.1539
Abstract
The motor score with and without levodopa was estimated in 193 parkinsonian patients with variable length of evolution. The effect of levodopa on akinesia, rigidity, and tremor remained quite stable during the course of the disease. In contrast, the aggravation of gait disorder, postural instability, and dysarthria was more severe, with decreased percentage of improvement on levodopa in patients with longer evolution. It is suggested that aggravation of Parkinson's disease mainly results from increasing severity of cerebral nondopaminergic lesions.This publication has 3 references indexed in Scilit:
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984
- Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementiaBrain Research, 1982
- ENZYMES ASSOCIATED WITH METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE AND HUNTINGTONS-CHOREA1976